Clinical Investigation of Wireless Transmission of Invasive Blood Pressure Signal
NCT ID: NCT01373996
Last Updated: 2011-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2011-06-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Non-Invasive Blood Pressure (NIBP) Using the Biobeat Device with an Invasive Arterial Line Catheter
NCT04071015
Comparison of the Non-invasive Biobeat Device With an Invasive Arterial Line
NCT03603860
Remote Symptom Review in Patients With Implantable Diagnostic Holter
NCT06431828
Development and Validation of a Telemonitoring System for High-risk Cardiovascular Patients
NCT05485532
The Use of Portable Wireless Monitor in Patient Vital Sign Monitoring
NCT06117111
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The HMW 10 Wireless System was developed and incorporates wireless transmission of patient's signal. The purpose of the study was to measure the quality of data transmitted through the HMW 10 Wireless System, and to demonstrate that the quality of the data meets the requirements of European Directive 93/42/EEC (Medical Device Directive - MDD) and EN/IEC 60601-1 and EN/IEC 60601-2-34.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wireless
Measuring of invasive arterial blood pressure through HMW10 Wireless System.
Wireless invasive blood pressure monitoring (Hybymed® Wireless IBPM System)
The readings of invasive arterial pressure were obtained from 2 identical pressure transducers, connected to a common arterial line via a Y connector. Data was collected from one transducer via a direct cable connection and from the second transducer via wireless transmission of the signal to the patient's bedside monitor using the HMW 10 Wireless System.
A comparison of data received by patient's bedside monitor from the two transducers was done (standard connection vs. wireless connection), as well as a comparison of data collected by the transmitter and data received by the receiver of the HMW 10 Wireless System.
Wired
Measuring of invasive arterial blood pressure through conventional wired technology.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wireless invasive blood pressure monitoring (Hybymed® Wireless IBPM System)
The readings of invasive arterial pressure were obtained from 2 identical pressure transducers, connected to a common arterial line via a Y connector. Data was collected from one transducer via a direct cable connection and from the second transducer via wireless transmission of the signal to the patient's bedside monitor using the HMW 10 Wireless System.
A comparison of data received by patient's bedside monitor from the two transducers was done (standard connection vs. wireless connection), as well as a comparison of data collected by the transmitter and data received by the receiver of the HMW 10 Wireless System.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hyb, d.o.o., Slovenia
UNKNOWN
University Medical Centre Ljubljana
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UMC Ljubljana
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Primoz Gradisek, MD
Role: PRINCIPAL_INVESTIGATOR
UMC Ljubljana
Neva Pozar-Lukanovic, MD, MMsc
Role: PRINCIPAL_INVESTIGATOR
UMC Ljubljana
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HMW10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.